Skip to main content
. 2023 Nov 2;67(2):290–300. doi: 10.1007/s00125-023-06034-y

Table 1.

Characteristics of the study cohort

Characteristic All participants
N=6256
Age, median [IQR] 12.21 [7.87–21.28]
Male sex, n (%) 3038 (48.6)
Number of AAbs, n (%)
 0 180 (2.9)
 1 2470 (39.5)
 2 1451 (23.2)
 3 963 (15.4)
 4 741 (11.8)
 5 451 (7.2)
Type of AAb, n (%)
 GAD65+ 4955 (79.2)
 IA-2+ 1900 (30.4)
 mIAA+ 2524 (40.3)
 ICA+ 2217 (35.4)
 ZNT8+ 1635 (26.1)
AAb ≥2, n (%) 3606 (57.6)
HLA–DR3 and/or DR4a, n (%) 4543 (79.1)
Dysglycaemia, n (%) 1462 (23.4)
BMI, median [IQR] 19.47 [16.28–24.49]
 Adults aged ≥18, median [IQR], n 26.09 [23.02–30.77], 1590
 Children <18, median [IQR], n 17.39 [15.69–20.61], 4024
BMIp, median [IQR] 52.18 [42.24–61.07]
 Adults aged ≥18, median [IQR], n 42.61 [23.32–65.50], 1589
 Children <18, median [IQR], n 53.26 [46.03–60.47], 4022
 Age of children <18 with a BMIp, median [IQR], n 9.62 [6.58–12.82], 4022
HOMA-IR, median [IQR] 1.36 [0.84–2.18]
Matsuda Index, median [IQR] 6.56 [4.23–10.26]
Index60, median [IQR] 0.04 [−0.69, 0.71]
IGI, median [IQR] 0.75 [0.41–1.31]

aHLA typing information was unavailable for 514 individuals